The severity of fatigue experienced by people with Sjögren’s disease affects their pain severity, and also has an impact…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Two global Phase 3 clinical trials are now testing dazodalibep, Amgen’s experimental therapy for Sjögren’s disease, in two…
Sjögren’s disease patients found significant relief from debilitating symptoms like dryness, pain, and fatigue after treatment with Johnson…
Prompt treatment for primary Sjögren’s disease in patients who develop ischemic stroke, where parts of the brain die due…
Anti-SSB antibodies may be a predictor of decreased lung function in people with primary Sjögren’s disease who also have…
More severe salivary gland damage and lymph node enlargement detected by ultrasound examination are associated with higher disease activity in…
People with primary Sjögren’s disease diagnosed at a younger age and who harbor certain self-reactive antibodies are more likely…
More than half of women with Sjögren’s disease show loss of bone tissue, or bone erosion, according to a…
People with Sjögren’s disease who are positive for self-reactive, anti-SSA antibodies may develop more severe dry eye symptoms than…
People with primary Sjögren’s disease and neuropathic pain — pain caused by damage or dysfunction of the nervous system…